WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Abhishek Tyagi
PeerJ Editor
3,235 Points

Contributions by role

Editor 3,235

Contributions by subject area

Biochemistry
Cell Biology
Molecular Biology
Oncology
Histology
Bioinformatics
Pathology
Nephrology
Pharmacology
Surgery and Surgical Specialties
Urology
Computational Biology
Women's Health
Medical Genetics
Epidemiology
Gastroenterology and Hepatology
Hematology
Immunology
Data Mining and Machine Learning
Data Science
Genomics
Geriatrics
Ophthalmology
Microbiology
Toxicology
Neurology
Respiratory Medicine
Evidence Based Medicine
Radiology and Medical Imaging
Translational Medicine
Dentistry
Computational Science
Internal Medicine

Abhishek Tyagi

PeerJ Editor

Summary

I have been working on the molecular mechanisms of cancer progression and metastasis for the last ten years, identifying signaling pathways that promote cancer progression using various in vitro and in vivo models. During this time, I have published 30 articles with more than 2000 citations, and 12 papers have been cited as being in the top 10% of the field. They have mostly appeared in high-impact journals such as Sci. Adv., Nat. Comm., J. Exp. Med., Clinical Can. Res., Oncogene, Cancer Res., Cancer Letters. My research is primarily concerned with mechanistic and translational studies of tumor-initiating cells, the microenvironment, and non-coding RNAs in the context of cancer progression and metastasis. My long-term research goal is to conduct basic and translational research to elucidate the underlying mechanism(s) driving cancer metastasis and identify therapeutic targets, especially for highly aggressive metastatic cancers. In addition, I also serve on the editorial boards of three cancer-related journals. Before joining the department of Cancer Biology at Wake Forest University School of Medicine, I was a senior research officer (SRO) at the Delhi State Cancer Institute, India (Govt. of India).
I am or have been...
1. A self-motivated, goal-oriented cellular/molecular biologist with over 7 years of experience in oncology.
2. Substantial experience in designing and executing well-controlled in vitro and in vivo assays for preclinical drug discovery, synthetic lethal screening, biomarker identification, target validation, immunogenicity, and toxicity assessment
3. Capable of investigating signaling pathways with a variety of molecular and genetic tools
4. Enthusiastic team worker and expert in forming strategic collaborations

Immunology Oncology Translational Medicine

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Work details

Senior Post-Doc Fellow

Wake Forest University School of Medicine
March 2017
Cancer Biology
Understanding the molecular mechanism of tumor metastasis and therapy resistance in breast and lung cancers

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 28

Academic Editor on

January 31, 2025
Bidirectional association between breast cancer and dementia: a systematic review and meta-analysis of observational studies
Fuxing Bao, Liang Yu, Xiaolei Zhang, Qier Mu
https://doi.org/10.7717/peerj.18888 PubMed 39902325
August 23, 2024
Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinoma
Kun Deng, Liqiang Yuan, Zhanyu Xu, Fanglu Qin, Zhiwen Zheng, Liuliu Huang, Wei Jiang, Junqi Qin, Yu Sun, Tiaozhan Zheng, Xinhuai Ou, Liping Zheng, Shikang Li
https://doi.org/10.7717/peerj.17816 PubMed 39193519
July 26, 2024
Association between the metabolic score for insulin resistance and prostate cancer: a cross-sectional study in Xinjiang
Jinru Wang, Aireti Apizi, Ning Tao, Hengqing An
https://doi.org/10.7717/peerj.17827 PubMed 39076779
January 17, 2024
Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma
Maoqing Jiang, Xiuyu Guo, Ping Chen, Xiaohui Zhang, Qiaoling Gao, Jingfeng Zhang, Jianjun Zheng
https://doi.org/10.7717/peerj.16807 PubMed 38250731
January 10, 2024
Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer
Shasha Li, Lulu Wang, Jing Shi, Yi Chen, Ang Xiao, Bingyue Huo, Wenjing Tian, Shilu Zhang, Gang Yang, Wensheng Gong, Huixia Zhang
https://doi.org/10.7717/peerj.16752 PubMed 38223760
November 27, 2023
Ropivacaine inhibits the malignant behavior of lung cancer cells by regulating retinoblastoma-binding protein 4
Weiai Jia, Junmei Shen, Sisi Wei, Chao Li, Jingpu Shi, Lianmei Zhao, Huiqun Jia
https://doi.org/10.7717/peerj.16471 PubMed 38034873
November 16, 2023
Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors
Chinmaya U. Joisa, Kevin A. Chen, Matthew E. Berginski, Brian T. Golitz, Madison R. Jenner, Gabriela Herrera Loeza, Jen Jen Yeh, Shawn M. Gomez
https://doi.org/10.7717/peerj.16342 PubMed 38025707
October 26, 2023
High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma
Wei Fei, Yan Yan, Guangjun Liu, Bo Peng, Yuanyuan Liu, Qiang Chen
https://doi.org/10.7717/peerj.16306 PubMed 37904848
October 11, 2023
Prognostic analyses of genes associated with anoikis in breast cancer
Jingyu Cao, Xinyi Ma, Guijuan Zhang, Shouyi Hong, Ruirui Ma, Yanqiu Wang, Xianxin Yan, Min Ma
https://doi.org/10.7717/peerj.15475 PubMed 37842046
August 7, 2023
The hypoxia-associated genes in immune infiltration and treatment options of lung adenocarcinoma
Liu Liu, Lina Han, Lei Dong, Zihao He, Kai Gao, Xu Chen, Jin-Cheng Guo, Yi Zhao
https://doi.org/10.7717/peerj.15621 PubMed 37576511
August 2, 2023
Mutation-derived, genomic instability-associated lncRNAs are prognostic markers in gliomas
Shenglun Li, Yujia Chen, Yuduo Guo, Jiacheng Xu, Xiang Wang, Weihai Ning, Lixin Ma, Yanming Qu, Mingshan Zhang, Hongwei Zhang
https://doi.org/10.7717/peerj.15810 PubMed 37547724
July 24, 2023
The prognostic significance of KLRB1 and its further association with immune cells in breast cancer
Ning Xu, Xiangyu Meng, Hongyu Chu, Zhaoying Yang, Yan Jiao, Youjun Li
https://doi.org/10.7717/peerj.15654 PubMed 37520246
July 12, 2023
Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study
Fei Hou, Yan Hou, Xiao-Dan Sun, Jia lv, Hong-Mei Jiang, Meng Zhang, Chao Liu, Zhi-Yong Deng
https://doi.org/10.7717/peerj.15678 PubMed 37456882
May 19, 2023
Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site
Garett Paul Ostdiek-Wille, Saber Amin, Shuo Wang, Chi Zhang, Chi Lin
https://doi.org/10.7717/peerj.15357 PubMed 37223122
April 19, 2023
Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis
Irem Congur, Ekin Koni, Onur Emre Onat, Zeynep Tokcaer Keskin
https://doi.org/10.7717/peerj.15250 PubMed 37096065
April 17, 2023
Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma
Ming Tan, Xiaoyu Lin, Huiying Chen, Wanli Ye, Jianqi Yi, Chao Li, Jinlan Liu, Jiping Su
https://doi.org/10.7717/peerj.15203 PubMed 37090107
March 6, 2023
METTL3-mediated m6A modification of has_circ_0007905 promotes age-related cataract progression through miR-6749-3p/EIF4EBP1
Rui Li, Haohao Zhu, Qian Li, Jiancen Tang, Yiping Jin, Hongping Cui
https://doi.org/10.7717/peerj.14863 PubMed 36908822
March 2, 2023
Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients
Paksiree Saranaruk, Sakda Waraasawapati, Yaovalux Chamgramol, Kanlayanee Sawanyawisuth, Natnicha Paungpan, Narumon Somphud, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham, Kulthida Vaeteewoottacharn
https://doi.org/10.7717/peerj.14883 PubMed 36883059
February 23, 2023
High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression
Peng Zhu, Yongyan Pei, Jian Yu, Wenbin Ding, Yun Yang, Fuchen Liu, Lei Liu, Jian Huang, Shengxian Yuan, Zongyan Wang, Fangming Gu, Zeya Pan, Jinzhong Chen, Jinrong Qiu, Huiying Liu
https://doi.org/10.7717/peerj.14891 PubMed 36855431
February 16, 2023
Splice site m6A methylation prevents binding of DGCR8 to suppress KRT4 pre-mRNA splicing in oral squamous cell carcinoma
Xiaoxu Li, Juan Fang, Xiaoan Tao, Juan Xia, Bin Cheng, Yun Wang
https://doi.org/10.7717/peerj.14824 PubMed 36811004
February 16, 2023
Advances in the study of aerobic glycolytic effects in resistance to radiotherapy in malignant tumors
Yuyi Liu, Zhengfu Feng, Pingmei Zhang, Honghao Chen, Song Zhu, Xin Wang
https://doi.org/10.7717/peerj.14930 PubMed 36811010
January 12, 2023
Models of ultrasonic radiomics and clinical characters for lymph node metastasis assessment in thyroid cancer: a retrospective study
Hui Zhu, Bing Yu, Yanyan Li, Yuhua Zhang, Juebin Jin, Yao Ai, Xiance Jin, Yan Yang
https://doi.org/10.7717/peerj.14546 PubMed 36650830
January 4, 2023
Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
Yang Zhang, Li Ding, Yuxin Zheng, Kun Wang, Wentao Xia, Junqi Wang, Peng Ge
https://doi.org/10.7717/peerj.14500 PubMed 36624752
December 20, 2022
Knockdown of hsa_circ_0008922 inhibits the progression of glioma
Chunhong Xue, Chang Liu, Xiang Yun, Xiaoqiong Zou, Xin Li, Ping Wang, Feng Li, Yingying Ge, Qingmei Zhang, Xiaoxun Xie, Xisheng Li, Bin Luo
https://doi.org/10.7717/peerj.14552 PubMed 36570001
December 19, 2022
Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
Lincheng Ju, Yaxing Shi, Gang Liu
https://doi.org/10.7717/peerj.14506 PubMed 36570012
December 15, 2022
Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors
Xiuqiong Chen, Zhaona Li, Jing Zhou, Qianhui Wei, Xinyue Wang, Richeng Jiang
https://doi.org/10.7717/peerj.14566 PubMed 36540802
November 10, 2022
The biological function of m6A methyltransferase KIAA1429 and its role in human disease
Xiaoyu Zhang, Meng jiao Li, Lei Xia, Hairong Zhang
https://doi.org/10.7717/peerj.14334 PubMed 36389416
November 4, 2022
Cigarette smoking induces the activation of RIP2/caspase-12/NF-κB axis in oral squamous cell carcinoma
Yajie Qian, Wenmei Wang, Deyan Chen, Yanan Zhu, Yong Wang, Xiang Wang
https://doi.org/10.7717/peerj.14330 PubMed 36353608